1Bowker SL,Majumdar SR,Veugelers P,et al.Increased cancer-related mortality for patients with type 2 diabetes who usesulfonylureas or insulin(J).Diabetes Care,2006;29:254-8.
2Davila JA,Morgan RO,Shaib Y,et al.Diabetes increases the risk of hep-atocellular carcinoma in the United States:a population based case control study(J).Gut,2005;54:533-9.
3Feng YH,Lin CY,Huang WT,et al.Diabetes mellitus impairs the re-sponse to intra-arterial chemotherapy in hepatocellular carcinoma(J).J Med Oncol,2010:24.
4LaiMS,Hsieh MS,Chiu YH,et al.Type 2 diabetes and hepatocellular carcinoma:a cohort study in high prevalence area ofhepatitis virus infec-tion(J).Hepatology,2006;43(6):1295-302.
6Sans S,PadróT,Tuomilehto J,et al.Incidence of diabetes and serum adipokines in Catalonian men.The ADIPOCAT study[J].Annals of Medicine,2013,45(1/2):97-102.
7Blanco S,Vaquero M,Gomez-Guerrero C.Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus,obesity and mild hypertension[J].American Journal of Hypertension,2005,18(4):557-565.
8Iijima K,Iimuro S,Shinozaki T,et al.Lower physical activity is a strong predictor of cardiovascular events in elderly patients with type2 diabetes mellitus beyond traditional risk factors:The Japanese elderly diabetes intervention trial[J].Geriatrics&Gerontology International,2012,12(Suppl 1):77-87.
